Biomarker‐based stability in limbic‐predominant amnestic mild cognitive impairment
Article 2020 en
Authors
GT
Giacomo Tondo
GC
Giulia Carli
RS
Roberto Santangelo
Abstract
1 min read
In a large series of clinically comparable subjects with aMCI at baseline, the specific [<sup>18</sup> F]FDG-PET limbic-predominant hypometabolism pattern was associated with clinical stability, making progression to AD very unlikely. The identification of a biomarker-based benign course in aMCI subjects has important implications for prognosis and in planning clinical trials.
Federica Agosta, Elisa Scola, Marco Bozzali, Giuseppe Magnani, M. Franceschi, Mara Cercignani, Elisabetta Pagani, Monica Falautano, Andrea Falini, Massimo Filippi
Discussion(0)
No comments yet. Be the first to comment.